Boehringer launches open innovation project for work-at-home scientists

Germany’s Boehringer Ingelheim is to make a bank of its molecules available to scientists in a bid to encourage open innovation during the COVID-19 pandemic, when many scientists are working from home.

The family-owned company has dubbed its new crowdsourcing platform opnMe, and aims to set new standards of collaboration within the scientific community.